Realising the full potential of data-enabled trials in the UK: a call for action
Rationale Clinical trials are the gold standard for testing interventions. COVID-19 has further raised their public profile and emphasised the need to deliver better, faster, more efficient trials for patient benefit. Considerable overlap exists between data required for trials and data already coll...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2021-06-01
|
| Серии: | BMJ Open |
| Online-ссылка: | https://bmjopen.bmj.com/content/11/6/e043906.full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
